With respect to biological features, all patients (n = 9) with inactive p53 and Her-2/neu coexpressing tumors and 8 out of 11 breast cancer patients (72.7%) with Her2/neu expression and intact p53 were negative for hormonal receptors (Table 6). Here, ERBB2 is linked to breast carcinoma.